Today’s deals: life sciences

Add Life Medical Institute Ltd. (a.k.a. Sterling), a Gujarat, India-based hospital group, has raised $15.5 million in growth capital funding from Actis.

Concert Pharmaceuticals Inc., a Boston-based drug development company using novel chemistry approaches, has raised $10 million in Series A funding, according to a regulatory filing. Backers include Three Arch Partners and Skyline Ventures.

DecisionView Inc., a San Francisco-based provider of software solutions that help optimize clinical drug trials, has secured $7.73 million of a $12.47 million Series B round, according to a regulatory filing. Adobe Ventures was joined by return backers Partech International and Granite Ventures.

Synta Pharmaceuticals Corp., a Lexington, Mass.-based small-molecule drug company, has raised $40 million in fifth-round funding. A regulatory filing refers to the securities as Series A convertible preferred stock, with Caxton Corp. and Luxor Capital Partners listed as significant shareholders. SunAmerica Ventures also participated. Synta has raised over $230 million in total VC funding since its 2001 inception.